Semaglutide
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 150
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
- Semaglutide 2.4 mg
- Placebo
- Semaglutide, on treatment
- Placebo, on treatment
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Semaglutide 2.4 mg | 96% | n/r | n/r | n/r |
| Placebo | 12% | n/r | n/r | n/r |
| Semaglutide, on treatment | 92% | n/r | n/r | n/r |
| Placebo, on treatment | 12% | n/r | n/r | n/r |
Not shown
Every selected arm is drawn.